Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | Suppliers

Human ADME and Studies with Radiolabeled Compounds: Phase I-IIa

Published 19 September 2014 | By PRA Health Sciences

Radiolabeled medication is widely used in the assessment of human ADME and also increasingly in assessing absolute bioavailability (BA). Conducting an ADME study early in the clinical development program - generally before or in parallel with Phase IIa - is prudent since the outcome may generate the need for additional toxicology studies.

Available Downloads

Human ADME and Studies with Radiolabeled Compounds: Phase I-IIa